Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP3A4 | P08684 | 20/20 | 0.89 |
| ▸ | CYP2D6 | P10635 | 7/20 | 0.89 |
| ▸ | CYP2C19 | P33261 | 4/20 | 0.89 |
| ▸ | CYP2C9 | P11712 | 4/20 | 0.89 |
| ▸ | MEN1 | O00255 | 1/20 | 0.89 |
| ▸ | SLC22A2 | O15244 | 1/20 | 0.89 |
| ▸ | SLC22A1 | O15245 | 1/20 | 0.89 |
| ▸ | ABCC3 | O15438 | 1/20 | 0.89 |
| ▸ | ABCC4 | O15439 | 1/20 | 0.89 |
| ▸ | MLNR | O43193 | 1/20 | 0.89 |
| ▸ | NR1I2 | O75469 | 1/20 | 0.89 |
| ▸ | SLCO2B1 | O94956 | 1/20 | 0.89 |
| ▸ | ABCB11 | O95342 | 1/20 | 0.89 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.89 |
| ▸ | PGR | P06401 | 1/20 | 0.89 |
| ▸ | ABCB1 | P08183 | 1/20 | 0.89 |
| ▸ | HTR1A | P08908 | 1/20 | 0.89 |
| ▸ | ADRA2A | P08913 | 1/20 | 0.89 |
| ▸ | ADORA3 | P0DMS8 | 1/20 | 0.89 |
| ▸ | MAPT | P10636 | 1/20 | 0.89 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7193802 | 0.95 | CYP3A4 (0.80) | CYP3A4CYP2D6CYP2C19CYP2C9MEN1 | |
| Ritonavir SCHEMBL20257193 | 0.94 | CYP3A4 (1.00) | CYP3A4CYP2D6CYP2C19CYP2C9MEN1 | |
| Ritonavir SCHEMBL17787453 | 0.94 | CYP3A4 (1.00) | CYP3A4CYP2D6CYP2C19CYP2C9MEN1 | |
| Ritonavir SCHEMBL6679 | 0.94 | CYP3A4 (1.00) | CYP3A4CYP2D6CYP2C19CYP2C9MEN1 | |
| Ritonavir SCHEMBL23927481 | 0.94 | CYP3A4 (1.00) | CYP3A4CYP2D6CYP2C19CYP2C9MEN1 | |
| Ritonavir SCHEMBL24777041 | 0.94 | CYP3A4 (1.00) | CYP3A4CYP2D6CYP2C19CYP2C9MEN1 | |
| Ritonavir SCHEMBL12175481 | 0.94 | CYP3A4 (1.00) | CYP3A4CYP2D6CYP2C19CYP2C9MEN1 | |
| Ritonavir SCHEMBL7806137 | 0.94 | CYP3A4 (1.00) | CYP3A4CYP2D6CYP2C19CYP2C9MEN1 | |
| Ritonavir SCHEMBL3178401 | 0.94 | CYP3A4 (1.00) | CYP3A4CYP2D6CYP2C19CYP2C9MEN1 | |
| Ritonavir SCHEMBL7531251 | 0.94 | CYP3A4 (1.00) | CYP3A4CYP2D6CYP2C19CYP2C9MEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 27 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-5583232-A | TREATING HUMAN IMMUNODEFICIENCY VIRUS INFECTIONS | ABBOTT LABORATORIES (US) | 1996-12-10 | — | — | US | claimed |
| US-6667404-B2 | Carbamylation of 1-amino group of 1,4-amino-3-hydroxybutane derivative with an organocarbonate containing thiazolyl, oxazolyl, isoxazolyl or isothiazolyl substituent | ABBOTT LABORATORIES | 2003-12-23 | — | — | US | disclosed |
| EP-1302468-A1 | Processes and intermediates for manufacturing retroviral protease inhibiting compounds | ABBOTT LABORATORIES (US) | 2003-04-16 | — | — | EP | disclosed |
| US-6531610-B1 | Intermediate acylating carbonate | ABBOTT LABORATORIES | 2003-03-11 | — | — | US | disclosed |
| EP-0727419-B1 | Intermediates for the preparation of retroviral protease inhibiting compounds | ABBOTT LAB (US) | 2002-02-27 | — | — | EP | disclosed |
| EP-1090914-A2 | Processes and intermediates for manufacturing retroviral protease inhibiting compounds | ABBOTT LABORATORIES (US) | 2001-04-11 | — | — | EP | disclosed |
| US-6150530-A | AMIDATION OF AMINE WITH ACID | ABBOTT LABORATORIES (US) | 2000-11-21 | — | — | US | disclosed |
| US-6017928-A | Retroviral protease inhibiting compounds | ABBOTT LABORATORIES (US) | 2000-01-25 | — | — | US | disclosed |
| US-5892052-A | Process for making retroviral protease inhibiting compounds | ABBOTT LABORTORIES (US) | 1999-04-06 | — | — | US | disclosed |
| US-5846987-A | Retroviral protease inhibiting compounds | ABBOTT LABORATORIES (US) | 1998-12-08 | — | — | US | disclosed |
| US-5608072-A | CONTAIN MONOSUBSTITUTED ISOXAZOLYL OR ISOTHIAZOLYL, SECONDARY AMIDE, CARBAMATE, HYDROXY, AND THIAZOLE OR OXAZOLE | ABBOTT LABORATORIES (US) | 1997-03-04 | — | — | US | disclosed |
| US-5597928-A | Retroviral protease inhibiting compounds | ABBOTT LABORATORIES (US) | 1997-01-28 | — | — | US | disclosed |
| US-5591860-A | Retroviral protease inhibiting compounds | ABBOTT LABORATORIES (US) | 1997-01-07 | — | — | US | disclosed |
| US-5583232-A | TREATING HUMAN IMMUNODEFICIENCY VIRUS INFECTIONS | ABBOTT LABORATORIES (US) | 1996-12-10 | — | — | US | disclosed |
| US-5583233-A | TREATING HUMAN IMMUNODEFICIENCY VIRUS INFECTIONS | ABBOTT LABORATORIES (US) | 1996-12-10 | — | — | US | disclosed |
| US-5565418-A | PREPARING CARBAMATE INTERMEDIATES BY REACTING SUBSTITUTED HYDROXYDIAMINE COMPOUND WITH ONE AMINE PROTECTED WITH ACTIVATED ACYLATING AGENT, DEPROTECTING | ABBOTT LABORATORIES (US) | 1996-10-15 | — | — | US | disclosed |
| EP-0674513-B1 | RETROVIRAL PROTEASE INHIBITING COMPOUNDS | ABBOTT LAB (US) | 1996-09-25 | — | — | EP | disclosed |
| EP-0727419-A2 | Retroviral protease inhibiting compounds | Abbott Laboratories (US) | 1996-08-21 | — | — | EP | disclosed |
| US-5541206-A | TREATING HUMAN IMMUNODEFICIENCY VIRUS INFECTION | ABBOTT LABORATORIES (US) | 1996-07-30 | — | — | US | disclosed |
| US-5539122-A | Retroviral protease inhibiting compounds | ABBOTT LABORATORIES (US) | 1996-07-23 | — | — | US | disclosed |